VPM1002

About Serum Life Science Europe

Serum Life Science Europe GmbH is a specialized consultancy and service provider for biopharmaceutical development, with deep expertise in vaccines and biologics. Originally founded as Vakzine Projekt Management GmbH with German federal support, the company now operates as an independent entity majority-owned by the Serum Institute of India (SIIPL). SLS Europe generates revenue through client services while advancing its own pipeline of three main clinical-stage assets, including a novel tuberculosis vaccine candidate.

Therapeutic Areas